Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia

NCT01649791 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

B-cell Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Stage 0 Chronic Lymphocytic Leukemia
Stage I Chronic Lymphocytic Leukemia
Stage II Chronic Lymphocytic Leukemia

Interventions

DRUG: lenalidomide
OTHER: laboratory biomarker analysis
PROCEDURE: lymph node biopsy
PROCEDURE: bone marrow aspiration
OTHER: pharmacological study
OTHER: flow cytometry

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]
[object Object]